683 Capital Management, LLC Cabaletta Bio, Inc. Transaction History

683 Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.08 - $12.62 $70,538 - $125,733	-9,963 Reduced 36.95%	17,000 $140,000
Q4 2022 Feb 14, 2023	BUY	$0.64 - $9.3 $17,256 - $250,755	26,963 New	26,963 $249,000
Q1 2022 May 16, 2022	SELL	$1.68 - $3.92 $60,678 - $141,582	-36,118 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $121,356 - $528,767	36,118 New	36,118 $137,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.